Scholars Central

Conference abstractPublished 23 Jul 2018

Prognostic role of tissue expression and serum level of YKL-40 in diffuse large B-cell lymphoma patients

Authors: Omnia Abd El-Fattah

Tanta University, Egypt

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Serum YKL-40 levels are increased in various inflammatory disorders and a wide range of malignancies. Moreover, these elevated levels correlate with poor prognosis of cancer patients, suggestive of YKL-40 might be a prognostic biomarker. The impact of YKL-40on non-Hodgkin lymphoma prognosis has not been fully explained. Aim: To study the serum levels and lymph node tissue expression of YKL-40 in diffuse large B-cell lymphoma (DLBCL) patients to assess its prognostic value and shed light on its impact on survival. Methods: The study included 60 DLBCL patients. ELISA was used to assess the serum YKL-40 levels. Immuno-histochemical staining was used to detect YKL-40 protein expression in lymphoma specimens. Results: YKL-40 serum levels were significantly higher in DLBCL patients when compared with the control group. YKL-40 was expressed in tumor tissue in 66.67% of patients. ReceiverâÂ?Â?operator curve analysis showed serum YKL-40 at a cut-off value of âÂ?¥ 95.5 (ng/mL) had a sensitivity of 70% and a specificity of 95% for DLBCL diagnosis. In DLBCL, Progression free and overall survival rates significantly decrease in patients with increased serum levels of YKL-40 above the cut off level and YKL- 40 positive expressed patients. Conclusions: Serum YKL-40 and its tissue expression could be a valuable prognostic marker in DLBCL patients.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Omnia Abd El-Fattah”